Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidine
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 140 (2) , 735-742
- https://doi.org/10.1016/0006-291x(86)90793-x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivityBiochemical Pharmacology, 1986
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- A Pathogenic Retrovirus (HTLV-III) Linked to AIDSNew England Journal of Medicine, 1984
- Effects of 2′,3′‐dideoxynucleosides on mammalian cells and virusesJournal of Cellular Physiology, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex VirusThe Journal of Infectious Diseases, 1980
- Fluoroimidazoles as antiviral agents and inhibitors of polynucleotide biosynthesisLife Sciences, 1975
- Nucleosides. x. The action of sodium ethoxide on 3′-Tetrahedron Letters, 1966
- Nucleosides. VIII. Synthesis of 2′,3′-unsaturated pyrimidine nucleosides from oxetane derivativesTetrahedron Letters, 1964